Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

KOBLAN KENNETH S — ALNYLAM PHARMACEUTICALS, INC. insider: 1 transactions · InsiderLens

Home / Insiders / KOBLAN KENNETH S

KOBLAN KENNETH S

Chief Scientific Officer at ALNYLAM PHARMACEUTICALS, INC. · on record since Dec 10, 2010

Insider trading activity of KOBLAN KENNETH S

Transactions on record: 1; since Dec 10, 2010

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Dec 10, 2010

Figures computed from official regulatory filings — methodology.

Companies where KOBLAN KENNETH S has traded

ALNYLAM PHARMACEUTICALS, INC.1 tx · Dec 10, 2010

Track record of KOBLAN KENNETH S

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of KOBLAN KENNETH S

Co-insiders of KOBLAN KENNETH S

Abingworth Management LTDALNYLAM PHARMACEUTICALS, INC.
Allen Patricia LALNYLAM PHARMACEUTICALS, INC.
Arbuckle Stuart AALNYLAM PHARMACEUTICALS, INC.
ARCH V ENTREPRENEURS FUND LPALNYLAM PHARMACEUTICALS, INC.
ARCH VENTURE FUND V LPALNYLAM PHARMACEUTICALS, INC.
ARCH VENTURE PARTNERS V LLCALNYLAM PHARMACEUTICALS, INC.
ARCH VENTURE PARTNERS V LPALNYLAM PHARMACEUTICALS, INC.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Arnold Stephen DALNYLAM PHARMACEUTICALS, INC.

Atlas Venture Associates VI, L.P.ALNYLAM PHARMACEUTICALS, INC.

ATLAS VENTURE ASSOCIATES V LPALNYLAM PHARMACEUTICALS, INC.

ATLAS VENTURE ENTREPRENEURS FUND VI LPALNYLAM PHARMACEUTICALS, INC.

ATLAS VENTURE ENTREPRENEURS FUND V LPALNYLAM PHARMACEUTICALS, INC.

Atlas Venture Fund VI GmbH & Co KGALNYLAM PHARMACEUTICALS, INC.

ATLAS VENTURE FUND VI LPALNYLAM PHARMACEUTICALS, INC.

ATLAS VENTURE FUND V LPALNYLAM PHARMACEUTICALS, INC.

ATLAS VENTURE PARALLEL FUND V-A C VALNYLAM PHARMACEUTICALS, INC.

ATLAS VENTURE PARALLEL FUND V-B C VALNYLAM PHARMACEUTICALS, INC.

Ausiello Dennis AALNYLAM PHARMACEUTICALS, INC.

Barrett PeterALNYLAM PHARMACEUTICALS, INC.

Berriman John EALNYLAM PHARMACEUTICALS, INC.

Bertozzi Carolyn RALNYLAM PHARMACEUTICALS, INC.

BONNEY MICHAEL WALNYLAM PHARMACEUTICALS, INC.

BRANDICOURT OLIVIERALNYLAM PHARMACEUTICALS, INC.

BYBEE CLINTONALNYLAM PHARMACEUTICALS, INC.

CHP II LPALNYLAM PHARMACEUTICALS, INC.

CLARKE JOHN KALNYLAM PHARMACEUTICALS, INC.

CRANDELL KEITHALNYLAM PHARMACEUTICALS, INC.

Cravatt BenjaminALNYLAM PHARMACEUTICALS, INC.

DZAU VICTOR JALNYLAM PHARMACEUTICALS, INC.

Fanucci MarshaALNYLAM PHARMACEUTICALS, INC.

Fitzgerald Kevin JosephALNYLAM PHARMACEUTICALS, INC.

Flint Jonathan AALNYLAM PHARMACEUTICALS, INC.

Franchini Indrani LallALNYLAM PHARMACEUTICALS, INC.

Garg PushkalALNYLAM PHARMACEUTICALS, INC.

Greene Barry EALNYLAM PHARMACEUTICALS, INC.

Greenstreet YvonneALNYLAM PHARMACEUTICALS, INC.

Gros David-Alexandre CALNYLAM PHARMACEUTICALS, INC.

HAMBURG MARGARET AALNYLAM PHARMACEUTICALS, INC.

Hesslein Robert W.ALNYLAM PHARMACEUTICALS, INC.

KEATING LAURIEALNYLAM PHARMACEUTICALS, INC.

KELLOGG PETER NALNYLAM PHARMACEUTICALS, INC.

LAZARUS STEVENALNYLAM PHARMACEUTICALS, INC.

MARAGANORE JOHNALNYLAM PHARMACEUTICALS, INC.

Mason MichaelALNYLAM PHARMACEUTICALS, INC.

MCGUIRE TERRANCEALNYLAM PHARMACEUTICALS, INC.

McLaughlin MelissaALNYLAM PHARMACEUTICALS, INC.

Miles Vincent JALNYLAM PHARMACEUTICALS, INC.

NELSEN ROBERTALNYLAM PHARMACEUTICALS, INC.

NOVARTIS AGALNYLAM PHARMACEUTICALS, INC.

NOVARTIS PHARMA AGALNYLAM PHARMACEUTICALS, INC.

Company	Filed	Type	Qty	Price	Value · USD	Src
ALNYLAM PHARMACEUTICALS, INC.	Dec 10, 2010	AwardD	10,000	0.00 USD	$0	SEC